JMP keeps Align at market outperform

JMP Securities analyst Anthony Ostrea reiterated Align Technology, Inc. at market outperform and an increased price target of $14 from $10. The company said in exchange for up to $20 million in payments to OrthoClear, OrthoClear agreed to exit the worldwide invisible aligner market, removing the OrthoClear overhang. The analyst raised his revenue estimate to $234 million from $204 million. Shares of the Santa Clara, Calif.-based dental products company were down 18 cents, or 1.56%, at $11.38. (Nasdaq: ALGN)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.